| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 144688-70-0 | 1-N-Boc-2-pyrrolidinonitrile | C10H16N2O2 |
| 144689-23-6 | 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid ethyl ester | C26H30N6O3 |
| 144689-24-7 | Olmesartan | C24H26N6O3 |
| 144689-63-4 | Olmesartan medoxomil | C29H30N6O6 |
| 144689-78-1 | Olmesartan | C30H32N6O6 |
| 144689-93-0 | Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate | C12H20N2O3 |
| 144689-94-1 | Diethyl 2-propylImidazoledicarbonate | C12H18O4N2 |
| 144690-04-0 | Olmesartan Impurity 17 | C10H16N2O3 |
| 144690-06-2 | Olmesartan Process Impurity 1 | C9H11N3O |
| 144690-33-5 | Trityl olmesartan ethyl ester | C45H44N6O3 |
| 144690-92-6 | Trityl olmesartan | C48H44N6O6 |
| 144701-20-2 | Fmoc-DL-Norleucine | C21H23NO4 |
| 144701-24-6 | Fmoc-D-Norvaline | C20H21NO4 |
| 144701-25-7 | Fmoc-3-cyclohexyl-D-alanine | C24H27NO4 |
| 144701-48-4 | Telmisartan | C33H30N4O2 |
| 144702-26-1 | 4'-[[1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl]-methyl]-1,1'-biphenyl-2-carboxylic acid 1,1-dimethylethyl ester | C37H38N4O2 |
| 144702-27-2 | 4'-[(1,4'-Dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carbonitrile | C33H29N5 |
| 144705-51-1 | 8-(2-Aminoethyl)-2-naphthalenol hydrobromide | C12H13NO.HBr |
| 144707-18-6 | 2-(2,3,4-Trihydroxyphenyl)-4H-1-benzopyran-4-one | C15H10O5 |
| 144735-57-9 | 2-(4-Hydroxy-3-methoxyphenyl)-7-methoxy-5-benzofuranpropanol | C19H20O5 |
| 144744-42-3 | (R)-alpha-Amino-2,6-difluorobenzeneacetic acid | C8H7F2NO2 |
| 144750-42-5 | alpha-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid hydrochloride | C15H14ClNO2S.HCl |
| 144750-52-7 | Clopidogrel Related Compound B | C16H17Cl2NO2S |
| 144758-28-1 | [3-(Trifluoromethyl)phenyl]malonic acid | C10H7F3O4 |
| 144763-44-0 | N1,N1,N4,N4-2-Naphthalenyl-1,4-benzenediamine | C46H32N2 |
| 144765-80-0 | Brachynoside heptaacetate | C45H54O22 |
| 144772-39-4 | Dibromochloroacetonitrile | C2Br2ClN |
| 144783-46-0 | 1-[4-(4-Morpholinyl)-3-nitrophenyl]ethanone | C12H14N2O4 |
| 144787-23-5 | N-[(Phenylmethoxy)carbonyl]-3-allyl-L-aspartic acid 1-tert-butyl ester | C19H25NO6 |
| 144796-70-3 | TNF-$greek945$(10-36) (human) | C131H211N43O38 |
| 144796-71-4 | L-Arginyl-L-arginyl-L-alanyl-L-asparaginyl-L-alanyl-L-leucyl-L-leucyl-L-alanyl-L-asparaginylglycyl-L-valyl-L-alpha-glutamyl-L-leucyl-L-arginyl-L-aspartic acid | C69H122N26O22 |
| 144796-96-3 | N6-(4-Amino-1-beta-D-ribofuranosyl-2(1H)-pyrimidinylidene)-L-lysine | C15H25N5O6 |
| 144797-57-9 | 3,5-Difluoro-4-chlorobenzonitrile | C7H2ClF2N |
| 144797-68-2 | 3,5-Difluorobenzamidine hydrochloride | C7H6F2N2.HCl |
| 144809-28-9 | 5-{4-[2-(5-Ethyl-2-pyridinyl)ethoxyl]benzylene}-2,4-thiazolidinedione | C19H18N2O3S |
| 144822-48-0 | 1-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-2-fluoro-beta-D-arabinofuranosyl]-5-methyl-2,4(1H,3H)-pyrimidinedione | C31H31FN2O7 |
| 144822-63-9 | 1-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-2-fluoro-beta-D-arabinofuranosyl]-2,4(1H,3H)-pyrimidinedione | C30H29FN2O7 |
| 144830-18-2 | (+)-N,O-Di-Desmethyl Tramadol | C14H21NO2 |
| 144843-25-4 | (SP-4-1)-[1,8,15,22-Tetrakis[2-methyl-1-(1-methylethyl)propoxy]-29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]copper | C60H72CuN8O4 |
| 144848-24-8 | (1R,3aR,7aR)-1-[(1R)-1,5-Dimethyl-5-[(triethylsilyl)oxy]hexyl]octahydro-7a-methyl-4H-inden-4-one | C24H46O2Si |
| 144851-61-6 | 2-Amino-3-fluorobenzotrifluoride | C7H5F4N |
| 144851-82-1 | 2-Amino-3-fluorobenzoic acid methyl ester | C8H8FNO2 |
| 144851-84-3 | 2-Amino-3-fluorobenzoic acid ethyl ester | C9H10FNO2 |
| 144868-15-5 | (S)-2-Diphenyphosphino-2'-hydroxyl-1,1'-binaphthyl | C32H23OP |
| 144868-17-7 | (S)-2-Diphenyphosphino-2'-ethyl-1,1'-binaphthyl | C34H27P |
| 144868-43-9 | Garjasmin | C11H12O5 |
| 144875-48-9 | Resiquimod | C17H22N4O2 |
| 144876-20-0 | 2-Piperidinecarboxaldehyde | C6H11NO |
| 144876-36-8 | 1H-Benzimidazole-4-carboxaldehyde | C8H6N2O |
| 144881-19-6 | Junipediol B | C10H12O4 |